Drug intelligence / Profile preview

Umune

Development stage
Unknown
Lead developer
Inmunotek
Modality
Vaccines & Immunotherapeutics
Administration
Sublingual
01

Overview

Umune is an individualized autologous bacterial vaccine (autovaccine) developed and marketed by Laboratorios Q Pharma. It is a personalized immunotherapy product custom-manufactured for each patient using specific bacterial strains isolated from their own clinical samples, such as urine or respiratory secretions. The vaccine consists of inactivated bacteria and is typically administered as a sublingual spray. It is primarily indicated for the prevention and treatment of recurrent infections, most notably recurrent urinary tract infections (rUTIs) and recurrent respiratory tract infections, particularly in patients who have not responded adequately to conventional antibiotic therapy. By exposing the patient's immune system to inactivated versions of the specific pathogens causing their chronic illness, Umune aims to induce a targeted immune response, thereby reducing the frequency and severity of subsequent infectious episodes.

Brand names
UmuneUmune Autovacuna
Other names
individualized autovaccineautovaccineautovacuna bacteriana

Beyond the preview

Go deeper on Umune.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Umune.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call